Star Voyage International Limited and Xuncheng Chen are reported as holding 9.94% of Universe Pharmaceuticals, equal to 497,917 Class A ordinary shares. For investors, the key distinction is the holders’ stated passive intent: the securities were not acquired or held to change or influence the company’s control.

Key Highlights

  • Star Voyage International reported beneficial ownership of 497,917 Class A ordinary shares.
  • The reported position represents 9.94% of Universe Pharmaceuticals INC’s Class A ordinary shares.
  • The filing states the securities were not acquired or held to change or influence control.

The reporting persons state that the securities were not acquired or held to change or influence control.

Ownership Structure and Share Count

The ownership report attributes the same 497,917 Class A ordinary shares and 9.94% interest to Chen. Universe Pharmaceuticals INC (NASDAQ: UPC) is identified as a Cayman Islands exempted company.

Passive Status Excludes Control-Change Purpose

The filing states that the securities were not acquired or held for the purpose or effect of changing or influencing control of Universe Pharmaceuticals INC.